SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

Escalating geopolitical tensions in the Middle East are driving significant community discussion around SPY, with market participants sharply divided on whether concerns over oil supply and broader stability will lead to a major downturn or present a "buy the dip" opportunity.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd ($INDO) is trending amidst escalating geopolitical tensions in the Middle East, with reports of attacks on Saudi oil facilities and disruptions in the Strait of Hormuz sparking expectations of surging oil prices. The community is actively discussing a potential massive short squeeze, comparing its low-float dynamics to previous parabolic runs during global conflicts and anticipating significant gains.

Invesco Capital Management LLC - Invesco QQQ Trust Series 1

QQQ is trending as the community debates the market's reaction to the escalating US-Iran conflict, with many anticipating a significant downturn due to surging oil prices and inflation concerns, while others expect a 'V-recovery' based on historical resilience and the belief that the geopolitical event is already priced in.

Battalion Oil Corp. engages in the acquisition, production, exploration, and development of liquids-rich oil and natural gas assets in the Delaware Basin. The company was founded in 1987 and is headquartered in Houston, TX.

Battalion Oil Corp - Ordinary Shares (New)

Surging as escalating Middle East tensions, including threats to oil supply routes and facilities, propel the energy sector, Battalion Oil (BATL) is captivating traders who are noting its explosive momentum and discussing potential for a short squeeze due to its low float.

United States Commodity Funds LLC - United States Oil Fund

United States Oil Fund

Escalating Middle East tensions are driving discussion around USO, fueled by US-Israeli strikes, Iran's retaliation, and significant shipping disruptions in the Strait of Hormuz. The community is actively debating whether these events signal a sustained crude oil rally or if the initial price spike will quickly dissipate.

Venture Global, Inc. engages in the development and construction of liquefied natural gas production, establishing us as a rapidly growing company delivering critical LNG to the world. It projects include Calcasieu, Plaquemines, CP2, CP3 and Delta projects. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending amid escalating geopolitical tensions impacting global LNG supply routes, sparking calls for a massive short squeeze and high anticipation for its upcoming earnings. The community is highlighting the company's rapid capacity expansion and strategic positioning as an undervalued leader poised for substantial growth in a tight energy market.

SSgA Active Trust - State Street SPDR Dow Jones Industrial Average ETF Trust

The DIA ETF is trending due to rapidly escalating geopolitical tensions in the Middle East, with community sentiment sharply divided between anticipating significant market corrections and viewing the situation as a "buy the dip" opportunity, alongside fresh tariff developments and hotter inflation data contributing to broad market volatility.

Applied Optoelectronics, Inc. engages in the design and manufacture of optical communications products. Its products include optical devices, such as laser diodes, photodiodes, related modules and circuitry, and equipment for applications in fiber-to-the-home, cable television, point to point communications, and wireless. The company was founded by Chih Hsiang Lin on February 28, 1997 and is headquartered in Sugar Land, TX.

Applied Optoelectronics Inc

Applied Optoelectronics is experiencing a massive rally following an earnings beat and aggressive revenue projections for its next-generation 800G and 1.6T optical transceivers, driven by the AI data center buildout. While bulls are celebrating potential revaluation and short squeeze, skeptics question management's ability to execute on these ambitious targets and highlight recent share dilution.

AeroVironment, Inc. engages in the design, development, and production of multi-domain robotic systems and related services for government agencies and businesses. It operates through the following business segments: UnCrewed Systems, Loitering Munitions Systems, and MacCready Work. The UnCrewed Systems segment focuses primarily on small UAS products designed to operate reliably at lower altitudes in a wide range of environmental conditions. The Loitering Munitions Systems segment focuses primarily on tube-launched aircraft that deploy with the push of a button, fly at higher speeds than small UAS products, and perform either effects delivery or reconnaissance missions, and related support services including training, spare parts, product repair, and product replacement. The MacCready Works segment focuses on customer-funded research and development in the areas of HAPS, robotics, sensors, software analytics, data intelligence, and connectivity. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending as multiple investment firms initiate or reiterate "Buy" ratings and aggressive price targets, fueled by a substantial U.S. Army contract win and the broader market's focus on escalating global defense spending and the burgeoning drone sector. The community is actively discussing its potential for continued growth as a leader in autonomous warfare solutions amid geopolitical tensions.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster is trending after acquiring StereoLabs, a strategic move widely seen by the community as foundational to becoming a unified Physical AI sensing and perception company, combining high-resolution lidar with AI vision and software to accelerate its path to profitability across robotics, industrial, and smart infrastructure markets.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Olema Pharmaceuticals CEO Touts Palazestrant Edge as Oral SERDs Shake Out at Conference

Olema Pharmaceuticals (NASDAQ:OLMA) President and CEO Sean Bohen said the company believes the emerging oral selective estrogen receptor degrader (SERD) class has proven its value over the past year...

Olema Pharmaceuticals CEO Teases Fall OPERA-01 Readout, Q2 KAT6 Data and CFO/COO Exit

Olema Pharmaceuticals (NASDAQ:OLMA) is focused on developing endocrine therapies aimed at improving outcomes for patients with estrogen receptor (ER)-positive, HER2-negative breast cancer, CEO Sean...

This Olema Pharmaceuticals Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Wednesday

Olema Pharmaceuticals (NASDAQ:OLMA) Now Covered by Analysts at Stifel Nicolaus

Stifel Nicolaus assumed coverage on Olema Pharmaceuticals in a research report on Wednesday. They set a "buy" rating and a $48.00 price target for the company...

Candriam S.C.A. Increases Stock Position in Olema Pharmaceuticals, Inc. $OLMA

Candriam S.C.A. raised its stake in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Free Report) by 46.9% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Given Consensus Rating of "Moderate Buy" by Analysts

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) has been given an average rating of "Moderate Buy" by the ten brokerages that are currently covering the company, MarketBeat reports. One...

Short Interest in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Decreases By 12.5%

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) was the recipient of a large decrease in short interest in January. As of January 15th, there was short interest totaling 9,100,561 shares...

Olema Pharmaceuticals (NASDAQ:OLMA) Trading 7.7% Higher - Here's What Happened

Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Up 7.7% - Here's Why...

Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells 10,000 Shares

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) Director Cyrus Harmon sold 10,000 shares of Olema Pharmaceuticals stock in a transaction on Tuesday, January 20th. The stock was sold at an...

Olema Pharmaceuticals (NASDAQ:OLMA) Director Cyrus Harmon Sells 10,000 Shares

Olema Pharmaceuticals, Inc. (NASDAQ:OLMA - Get Free Report) Director Cyrus Harmon sold 10,000 shares of the firm's stock in a transaction that occurred on Tuesday, January 20th. The shares were sold...

Olema Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which focuses on the discovery, development, and commercialization of next generation targeted therapies for women’s cancers. Its product candidate, OP-1250, is a novel oral therapy with combined activity as both a complete ER antagonist, or CERAN, and a selective ER degrader, or SERD, which is believed to drive deeper, more durable responses than existing therapies. The company was founded by Cyrus L. Harmon and Peter J. Kushner on August 7, 2006 and is headquartered in San Francisco, CA.

Olema Pharmaceuticals Inc

Day trading

Swing trading

Long-term investing

Sitting in cash

Markets have been volatile, with macro headlines and earnings driving sharp moves. How are you positioning right now?

Drop your approach below 👇

OLMA
Olema Pharmaceuticals Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest OLMA News

OLMAOlema Pharmaceuticals Inc